Study of Anti-HIVCellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus

針對症狀 Anti-HIV
臨床試驗編號 NCT02766049
臨床階段 Phase I/II
臨床試驗位址 University of Sao Paulo General Hospital
目前研究進度 This study has been completed.
試驗開始日期 May 9, 2016
試驗開始日期 July 20, 2016

The aim of this study was to assess tolerability and safety of three different formulations of an anti-HIV immunotherapy based on autologous dendritic cells (DCs) pulsed with HIV chemically inactivated with Aldrithiol™-2 (AT-2). Patients were chronically infected with HIV, naïve for antiretroviral drugs. A possible immunological and virological favorable impact was also assessed.